Archive · 19 Dec 2025
Trump to announce drug price deals
President Trump is going to tell everyone about new deals he made with big medicine companies.
These deals are supposed to make medicines cheaper for people in the US.
The announcement will happen at the White House on December 19.
Some of the companies involved are AbbVie, Bristol Myers Squibb, Gilead Sciences, Merck, Novartis, and Roche.
Before this, five other companies had already made similar deals with the government.
The goal is to make sure that medicines don't cost too much money.
US President Donald Trump to announce new agreements on December 19 to lower prescription drug prices.
Major pharmaceutical companies involved include AbbVie, Bristol Myers Squibb, Gilead Sciences, Merck, Novartis, and Roche.
Five companies have already reached agreements with the administration to control prices.
The remaining 12 companies include Sanofi, Regeneron, Merck, Johnson & Johnson, AbbVie, Amgen, Gilead, Boehringer Ingelheim, Bristol Myers, GSK, Novartis, and Genentech.
Novartis and Roche have expressed support for Trump's goal of reducing drug costs.
- Who
- US President Donald Trump, major pharmaceutical companies (AbbVie, Bristol Myers Squibb, Gilead Sciences, Merck, Novartis, Roche)
- What
- Announcement of new agreements to lower prescription drug prices
- When
- December 19 at 1 p.m. ET
- Where
- White House
- Why
- To lower prescription drug prices in the US
- Event Date
- December 19
- Event Time
- 1 p.m. ET
- Event Location
- White House
- Companies Involved
- AbbVie, Bristol Myers Squibb, Gilead Sciences, Merck, Novartis, Roche
- Previous Agreements
- Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk, EMD Serono
- Remaining Companies
- Sanofi, Regeneron, Merck, Johnson & Johnson, AbbVie, Amgen, Gilead, Boehringer Ingelheim, Bristol Myers, GSK, Novartis, Genentech